159 related articles for article (PubMed ID: 3085021)
1. [Acromegaly. Physiopathological aspects and description of a clinical case].
Coppola A; Spera C; Buono V; Esposito C; Nasti A
Minerva Med; 1986 Mar; 77(11):395-401. PubMed ID: 3085021
[TBL] [Abstract][Full Text] [Related]
2. Etiology of pituitary acromegaly.
Melmed S
Endocrinol Metab Clin North Am; 1992 Sep; 21(3):539-51. PubMed ID: 1521511
[TBL] [Abstract][Full Text] [Related]
3. [Acromegaly. Recent physiopathological and therapeutic acquisitions].
Silvestrini F
Minerva Med; 1979 Mar; 70(15):1065-8. PubMed ID: 108635
[No Abstract] [Full Text] [Related]
4. Heterogeneity of growth hormone (GH) release by individual pituitary adenoma cells from acromegalic patients, as determined by the reverse hemolytic plaque assay: effects of SMS 201-995, GH-releasing hormone and thyrotropin-releasing hormone.
Hofland LJ; van Koetsveld PM; van Vroonhoven CC; Stefanko SZ; Lamberts SW
J Clin Endocrinol Metab; 1989 Mar; 68(3):613-20. PubMed ID: 2493040
[TBL] [Abstract][Full Text] [Related]
5. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
[TBL] [Abstract][Full Text] [Related]
6. [Neuroaminergic control of anterior pituitary secretions (author's transl)].
Mornex R; Jordan D; Pickering A
Pathol Biol (Paris); 1976 Oct; 24(8):555-74. PubMed ID: 10544
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of acromegaly.
Melmed S; Braunstein GD; Horvath E; Ezrin C; Kovacs K
Endocr Rev; 1983; 4(3):271-90. PubMed ID: 6354702
[TBL] [Abstract][Full Text] [Related]
8. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Plöckinger U; Quabbe HJ
Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
[TBL] [Abstract][Full Text] [Related]
9. Effect of thyrotropin-releasing hormone and bromoergocriptine on growth hormone and prolactin secretion in perfused pituitary adenoma tissues of acromegaly.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1978 Dec; 47(6):1251-6. PubMed ID: 122426
[TBL] [Abstract][Full Text] [Related]
10. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F
J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic control of anterior pituitary hormone secretion--characterized hypothalamic-hypophysiotropic peptides.
Grant GF; Vale W
Curr Top Exp Endocrinol; 1974; 2():37-72. PubMed ID: 4208407
[No Abstract] [Full Text] [Related]
12. [Correlations between the secretory function of pituitary tumors and arterial hypertension in acromegaly].
Zgliczyński S; Słowińska-Srzednicka J; Puciłowska J; Jeske W; Kaniewski M
Endokrynol Pol; 1987; 38(5):371-8. PubMed ID: 3454744
[No Abstract] [Full Text] [Related]
13. Studies on pituitary function in patients with B-cell adenoma.
Zaccaria M; Giordano G; Vettor R; Ragazzi E; Boscaro M; Federspil G; Scandellari C
Horm Metab Res; 1983 Nov; 15(11):562-3. PubMed ID: 6317536
[No Abstract] [Full Text] [Related]
14. Intrasellar pituitary gangliocyto-adenoma presenting with acromegaly: case report.
Puchner MJ; Herrmann HD
Neurosurgery; 1998 May; 42(5):1197-9. PubMed ID: 9588573
[No Abstract] [Full Text] [Related]
15. Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration.
Candrina R
Recenti Prog Med; 1991 Jan; 82(1):13-6. PubMed ID: 1902962
[TBL] [Abstract][Full Text] [Related]
16. [Results of the clinical and electroencephalographic studies in patients with acromegaly of different etiologies].
Pronin VS; Frenkel' GM
Probl Endokrinol (Mosk); 1983; 29(2):44-52. PubMed ID: 6407000
[TBL] [Abstract][Full Text] [Related]
17. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
Matsukura S; Kakita T; Hirata Y; Yoshimi H; Fukase M
J Clin Endocrinol Metab; 1977 Feb; 44(2):392-7. PubMed ID: 190256
[TBL] [Abstract][Full Text] [Related]
18. Conventional pituitary irradiation in acromegaly. Effect on growth hormone and TSH secretion.
Lamberg BA; Kivikangas V; Vartianen J; Raitta C; Pelkonen R
Acta Endocrinol (Copenh); 1976 Jun; 82(2):267-81. PubMed ID: 818860
[TBL] [Abstract][Full Text] [Related]
19. Endocrine and immunohistochemical studies on thyrotropin (TSH)-secreting pituitary adenomas: responses of TSH, alpha-subunit, and growth hormone to hypothalamic releasing hormones and their distribution in adenoma cells.
Kuzuya N; Inoue K; Ishibashi M; Murayama Y; Koide Y; Ito K; Yamaji T; Yamashita K
J Clin Endocrinol Metab; 1990 Nov; 71(5):1103-11. PubMed ID: 1699960
[TBL] [Abstract][Full Text] [Related]
20. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
